Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 Trial

Abroad (travel likely)Recruiting

Conditions

Interstitial Lung Disease (ILD) · Suspected Interstitial Lung Disease · Fibrotic Interstitial Lung Disease · Idiopathic Pulmonary Fibrosis (IPF) · Interstitial Lung Disease Due to Connective Tissue Disease (Disorder)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Hospital General de Granollers, Granollers, Barcelona, Spain
Contact: Study coordinator (Jaume Bordas-Martínez, MD, PhD) · jbordas@fphag.org · +34 938 425 000

Study leads

Jaume Bordas-Martinez, MD, PhD
Principal Investigator
Hospital General de Granollers

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)

Interstitial Lung Disease

Abroad (travel likely)Recruiting

Rochester, United States

Skeletal Muscle Function in Interstitial Lung Disease

Interstitial Lung Disease · Idiopathic Pulmonary Fibrosis · Hypersensitivity Pneumonitis

Abroad (travel likely)Recruiting

Vancouver, Canada

Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease

Asthma · COPD · Interstitial Lung Disease

Abroad (travel likely)RecruitingPHASE1

Kansas City, United States

Collagen-targeted PET Imaging for Early Interstitial Lung Disease

Interstitial Lung Disease

Abroad (travel likely)RecruitingPHASE2

Boston, United States